Kemin’s immune-health ingredient BetaVia Complete now approved as Novel Food in Thailand
The Thailand Food and Drug Administration (TFDA) approved the algae-derived beta-glucan ingredient in food supplements for humans at a 375-mg daily dose.
Kemin (Des Moines, IA) reports that the Thailand Food and Drug Administration (TFDA) has approved Kemin’s BetaVia Complete immune health ingredient, granting it Novel Food status. The algae-derived beta-glucan ingredient can now be used in food supplements for humans in Thailand at a daily dose of 375 mg.
“BetaVia Complete is derived from Euglena gracilis, Kemin’s proprietary strain of algae known for its high level of beta-1,3-glucan and protein content, which also contains essential fatty acids,” the company’s press release states.
BetaVia also holds regulatory approvals in the U.S. and European Union. The ingredient “helps train the body’s natural defenses, supports respiratory tract health, and protects intestinal barrier integrity,” the press release states.
Senate Committee has released the text of 2024 Farm Bill, with changes to hemp regulations
November 19th 2024The U.S. Senate Committee on Agriculture, Nutrition, & Forestry has introduced the Rural Prosperity and Food Security Act, which will serve as the Senate’s draft for the 2024 Farm Bill.
NPA’s lawsuit against FDA on NMN stayed pending agency’s decision on citizen petition
November 6th 2024The court has granted a joint motion for stay filed by NPA and FDA, pending the agency's decision on the citizen petition asking FDA to reverse its stance on NMN's status as a dietary ingredient.
